DGN
D-GLUTAMINE
Find entries where: DGN
is present as a standalone ligand in 1 entries
as a non-polymer is covalently linked to polymer or other heterogen groups 3 entries
is present in a polymer sequence 80 entries
Chemical Component Summary | |
---|---|
Name | D-GLUTAMINE |
Identifiers | (2R)-2,5-diamino-5-oxo-pentanoic acid |
Formula | C5 H10 N2 O3 |
Molecular Weight | 146.144 |
Type | D-PEPTIDE LINKING |
Isomeric SMILES | C(CC(=O)N)[C@H](C(=O)O)N |
InChI | InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m1/s1 |
InChIKey | ZDXPYRJPNDTMRX-GSVOUGTGSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 20 |
Chiral Atom Count | 1 |
Bond Count | 19 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB02174 |
---|---|
Name | D-Glutamine |
Groups | experimental |
Description | A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. |
Synonyms |
|
Categories |
|
CAS number | 5959-95-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Glutamate racemase | MKIGIFDSGVGGLTVLKAIRNRYRKVDIVYLGDTARVPYGIRSKDTIIRY... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 6992096, 145815 |
ChEMBL | CHEMBL1232207 |
ChEBI | CHEBI:17061, CHEBI:58000 |
CCDC/CSD | LAQZUB |